Claims for Patent: 6,409,719

Summary for Patent: 6,409,719

Title:	Light stint implant device for treatment of long term viral infection
Abstract:	A light stint implant device adapted to be surgically implanted in a major blood vessel for assisting in the treatment of long term viral infection, alone or in combination with anti-viral drugs, is disclosed. The implant device is programmed for set periods of illumination and set periods of dormancy through a remote power supply and timing device accessible through a sub-dermal implant adapted to be surgically placed in a location under the skin. The device, after being implanted within such blood vessel will eliminate viruses located within the blood through exposure to light given off by the light stint implant device during the periods of illumination.
Inventor(s):	Manning; Don A. (Monroeville, AL)
Assignee:
Application Number:	09/663,786
Patent Claims:	1. A light stint implant device adapted to be surgically implanted in a major artery for assisting in the treatment of long term viral infection, alone or in combination with anti-viral drugs, the invention comprising: a. a thin, hollow, cylindrical illuminating light stint adapted to be implanted within the major artery having an illuminating means, an inner surface and an outer surface, the outer surface being provided with electrodes; b. a pair of electronic leads having a first end and a second end, the first end of the electronic leads connected to the electrodes on the outer surface of the illuminating light stint; and c. a control unit containing a removable access panel, an inner low voltage, long-term power supply connected to the second end of the electronic leads and a programmable timing means connected to the inner low voltage, long-term power supply to periodically activate the inner low voltage, long-term power supply causing such inner low voltage, long-term power supply to activate the illuminating means in the illuminating light stint providing light to the inner surface of the illuminating light stint and blood flowing along the inner surface of the illuminating light stint. 2. The invention as disclosed in claim 1, wherein the illuminating means provides light in the infrared, visible and ultraviolet spectrum. 3. The invention, as disclosed in claim 1, wherein the invention is utilized in conjunction with leukine and sargramostim for the treatment of AIDS. 4. The invention as disclosed in claim 1, further comprising the control unit having a remote transmission receiver for remotely reprogramming the programmable timing means, avoiding the need to access such programmable timing means through the removable access panel.

Details for Patent 6,409,719

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Partner Therapeutics, Inc.	LEUKINE	sargramostim	For Injection	103362	03/05/1991		2039-02-26
Partner Therapeutics, Inc.	LEUKINE	sargramostim	Injection	103362	03/05/1991		2039-02-26